Issued Patents All Time
Showing 1–20 of 20 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 11352405 | GLP-1/glucagon receptor agonists in the treatment of fatty liver disease and steatohepatitis | Aimo Kannt, Maximilian BIELOHUBY, Ralf Elvert, Michael Wagner, Torsten Haack +2 more | 2022-06-07 |
| 11141489 | Conjugates comprising an GLP-1/Glucagon dual agonist, a linker and hyaluronic acid | Dieter Kadereit, Michael Wagner, Thomas Olpp, Nino Meyer, Andreas Evers +5 more | 2021-10-12 |
| 11046743 | Selective glucagon receptor agonists comprising a chelating moiety for imaging purposes | Torsten Haack, Oliver Plettenburg, Andreas Evers, Michael Wagner, Romain BERTRAND | 2021-06-29 |
| 10806797 | Prodrugs comprising an GLP-1/glucagon dual agonist linker hyaluronic acid conjugate | Dieter Kadereit, Michael Wagner, Thomas Olpp, Nino Meyer, Pradeep K. Dhal +7 more | 2020-10-20 |
| 10792367 | Conjugates comprising an GLP-1/glucagon dual agonist, a linker and hyaluronic acid | Dieter Kadereit, Michael Wagner, Thomas Olpp, Nino Meyer, Andreas Evers +5 more | 2020-10-06 |
| 10758592 | Exendin-4 derivatives as dual GLP1/glucagon agonists | Torsten Haack, Michael Wagner, Bernd Henkel, Siegfried Stengelin, Andreas Evers | 2020-09-01 |
| 10538567 | Compounds as peptidic trigonal GLP1/glucagon/GIP receptor agonists | Andreas Evers, Torsten Haack, Dieter Kadereit, Katrin Lorenz, Michael Wagner +2 more | 2020-01-21 |
| 10519211 | Compounds as peptidic GLP1/glucagon/GIP receptor agonists | Andreas Evers, Torsten Haack, Katrin Lorenz, Dieter Kadereit, Michael Wagner +2 more | 2019-12-31 |
| 9982029 | Exendin-4 derivatives as selective peptidic dual GLP-1/glucagon receptor agonists | Andreas Evers, Torsten Haack, Katrin Lorenz, Dieter Kadereit, Michael Wagner +1 more | 2018-05-29 |
| 9775904 | Exendin-4 derivatives as peptidic dual GLP-1/glucagon receptor agonists | Ralf Elvert, Andreas Evers, Torsten Haack, Siegfried Stengelin, Michael Wagner | 2017-10-03 |
| 9771406 | Peptidic dual GLP-1/glucagon receptor agonists derived from exendin-4 | Ralf Elvert, Andreas Evers, Torsten Haack, Siegfried Stengelin, Michael Wagner +1 more | 2017-09-26 |
| 9758561 | Dual GLP-1/glucagon receptor agonists derived from exendin-4 | Ralf Elvert, Andreas Evers, Torsten Haack, Siegfried Stengelin, Michael Wagner +1 more | 2017-09-12 |
| 9694053 | Dual GLP-1/glucagon receptor agonists | Torsten Haack, Michael Wagner, Bernd Henkel, Siegfried Stengelin, Andreas Evers +1 more | 2017-07-04 |
| 9365632 | Exendin-4 derivatives as dual GLP1/glucagon agonists | Torsten Haack, Michael Wagner, Bernd Henkel, Siegfried Stengelin, Andreas Evers | 2016-06-14 |
| 9221784 | Benzo[1,3]dioxine derivatives and their use as LPAR5 antagonists | Marc Nazare, Detlef Kozian, Werngard Czechtizky, Andreas Evers | 2015-12-29 |
| 8853412 | Pyrrolidinone derivatives as GPR119 modulators for the treatment of diabetes, obesity, dyslipidemia and related disorders | Lothar Schwink, Heiner Glombik, Matthias Gossel, Dieter Kadereit, Thomas Klabunde +2 more | 2014-10-07 |
| 7968546 | Pyridazinone kinase inhibitors | Swen Hoelder, Gunter Muller, Karl Schoenafinger, David William Will, Hans Matter +5 more | 2011-06-28 |
| 7727989 | 4-benzimidazol-2-yl-pyridazine-3-one-derivatives, production and use thereof in medicaments | Karl Schoenafinger, Swen Hoelder, David William Will, Hans Matter, Guenter Mueller | 2010-06-01 |
| 7709466 | Pyridazinone derivatives, methods for their production and their use as pharmaceuticals | Swen Hoelder, Karl Schoenafinger, David William Will, Hans Matter, Guenter Mueller | 2010-05-04 |
| 7507734 | Pyridazinone derivatives | Swen Hoelder, Gunter Muller, Karl Schoenafinger, David William Will, Hans Matter +5 more | 2009-03-24 |